To evaluate the safety and efficacy of autologous bone marrow-derived mononuclear cell transplantation in-patient with neurological sequelae due to encephalitis or meningitis
The purpose of this study is to evaluate the safety and effectiveness of autologous bone marrow-derived mononuclear cell in 22 patients with neurological sequelae due to encephalitis or meningitis at Vinmec International Hospital, Hanoi, Vietnam
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
22
Transplantation of Autologous Bone Marrow Mononuclear Cells
Vinmec Research Institute of Stem Cell and Gene Technology
Hanoi, Vietnam
Change in Total Score of Gross Motor Function Measure (GMFM-88)
The Gross Motor Function Measure - 88 items (GMFM-88) is a standardized observational tool used to evaluate changes in gross motor function in children with cerebral palsy and other disabilities. The total score ranges from 0 to 264, with higher scores representing better gross motor function
Time frame: Baseline, 6 months, and 12 months after transplantation
Change in Muscle Tone Assessed by Modified Ashworth Scale (MAS)
The Modified Ashworth Scale (MAS) is a clinical tool used to measure muscle tone and the degree of spasticity in patients with neurological conditions. The scale ranges from 0 to 4, with an additional 1+ category. Scores are interpreted as follows: 0 indicates no increase in muscle tone, 1 indicates a slight increase in muscle tone with a catch and release, 1+ indicates a slight increase with minimal resistance throughout the remainder of the range of motion, 2 indicates a more marked increase in muscle tone through most of the range of motion, 3 indicates considerable increase in muscle tone making passive movement difficult, and 4 indicates that the affected part(s) are rigid in flexion or extension. Lower scores represent better outcomes (normal muscle tone), while higher scores represent worse outcomes
Time frame: Baseline, 6 months, and 12 months after transplantation
Number of adverse events
Examples of adverse events to look for: fever, infections, vomit, epilepsy
Time frame: Through study completion, an average of 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.